000 | 01114 a2200301 4500 | ||
---|---|---|---|
005 | 20250517001647.0 | ||
264 | 0 | _c20150622 | |
008 | 201506s 0 0 eng d | ||
022 | _a1473-6551 | ||
024 | 7 |
_a10.1097/WCO.0000000000000144 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWoehrer, Adelheid | |
245 | 0 | 0 |
_aGlioblastoma survival: has it improved? Evidence from population-based studies. _h[electronic resource] |
260 |
_bCurrent opinion in neurology _cDec 2014 |
||
300 |
_a666-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 | _aCommunity Health Planning |
650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aTemozolomide |
700 | 1 | _aBauchet, Luc | |
700 | 1 | _aBarnholtz-Sloan, Jill S | |
773 | 0 |
_tCurrent opinion in neurology _gvol. 27 _gno. 6 _gp. 666-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/WCO.0000000000000144 _zAvailable from publisher's website |
999 |
_c24324000 _d24324000 |